AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Lamictal wins FDA approval.

Pain & Central Nervous System Week

| July 21, 2003 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 JUL 21 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) announced the U.S. Food and Drug Administration's (FDA) approval of Lamictal (lamotrigine) tablets for the long-term maintenance treatment of bipolar I disorder.

Specifically, FDA approved Lamictal for the maintenance treatment of adults with bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy.

Additionally, the FDA has noted that findings for Lamictal maintenance treatment were more robust in bipolar depression. Maintenance treatment of bipolar depression is one of…

Related articles from newspapers, magazines, journals, and more
Lamictal wins FDA approval.
Newspaper article from: Drug Week July 25, 2003 700+ words
...The effectiveness of Lamictal in the acute treatment of mood episodes has not been established. Lamictal is the first FDA...these studies show Lamictal significantly delays...to intervention for mood episodes (depression, mania...
Lamictal: First medication since lithium approved for long-term maintenance...
News wire article from: Asia Africa Intelligence Wire June 23, 2003 700+ words
...The effectiveness of Lamictal in the acute treatment of mood episodes has not been established. Lamictal is the first FDA...these studies show Lamictal significantly delays...to intervention for mood episodes in patients with bipolar...
Lamictal: First Medication since Lithium Approved for Long-term Maintenance...
Press release article from: PR Newswire June 23, 2003 700+ words
...The effectiveness of Lamictal in the acute treatment of mood episodes has not been established. Lamictal is the first FDA...these studies show Lamictal significantly delays...to intervention for mood episodes (depression, mania...
New Expanded Indication For Lamictal(R) Offers Additional Treatment Options For...
Press release article from: PR Newswire January 15, 2004 700+ words
...treated for acute mood episodes with standard therapy...FDA approval for Lamictal supports the overall...treated for acute mood episodes with standard therapy...effectiveness of Lamictal in the acute treatment of mood episodes has not been established...
Long-term treatment with Lamictal not associated with significant weight gain.
Newspaper article from: Obesity, Fitness & Wellness Week June 5, 2004 700+ words
...the time to occurrence of mood episodes (depression, mania, hypomania...patients treated for acute mood episodes with standard therapy. The effectiveness of Lamictal in the acute treatment of mood episodes has not been established...
Long-Term Treatment With Lamictal Is Not Associated With Clinically Relevant...
Press release article from: PR Newswire May 5, 2004 700+ words
...treated for acute mood episodes with standard therapy. The effectiveness of Lamictal in the acute treatment of mood episodes has not been established...The effectiveness of Lamictal in the acute treatment of mood episodes has not been established...
GSK'S Lamictal Filed With FDA For First-Ever Indication In Long-Term Management...
Press release article from: PR Newswire August 29, 2002 700+ words
...application for approval of Lamictal as long-term management...patients demonstrated Lamictal significantly delayed the relapse/recurrence of mood episodes, particularly depressive...In these trials, Lamictal significantly delayed...
Lamictal filed with FDA for indication in depressive episodes.
Newspaper article from: Pain & Central Nervous System Week October 14, 2002 700+ words
...application for approval of Lamictal as long-term management...patients demonstrated Lamictal significantly delayed the relapse/recurrence of mood episodes, particularly depressive...In these trials, Lamictal significantly delayed...
Press Release: GSK'S Lamictal filed with FDA for first-ever indication in...
News wire article from: Asia Africa Intelligence Wire August 29, 2002 700+ words
...Administration (FDA) for Lamictal (lamotrigine). The application for approval of Lamictal as long-term management...adult patients demonstrated Lamictal significantly delayed the relapse/recurrence of mood episodes, particularly depressive...
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets.
Press release article from: PR Newswire May 11, 2009 700+ words
...orally disintegrating formulation. Lamictal ODT is indicated for the long...Disorder to lengthen the time between mood episodes in people 18 years or older who...other medicine. It is not known if Lamictal ODT is safe or effective in children...
For more facts and information, see all results

Source: HighBeam Research, Lamictal wins FDA approval.

©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily